However, in pathological conditions, as in cancer cells, one of the strategies to overcome this mechanism relies on aberrant post-translational modifications, such as O-GlcNAcylation of FH-AMPK phosphorylation sites, resulting in the disruption of FH-ATF2-mediated signaling thus promoting aberrant cell growth [50]. This evidence concerns the gene FH and cancer.